By Diana Novak Jones

(Reuters) -Kimberly-Clark said on Monday it plans to acquire Band-Aid maker Kenvue, even as the latter company faces thousands of lawsuits involving its painkiller Tylenol and talc-based baby powder, raising questions about the scope of the liabilities Kimberly-Clark might inherit.

Here is where those cases stand.

TYLENOL

On November 17, a U.S. appeals court is slated to hear arguments over whether to revive hundreds of lawsuits consolidated in multidistrict litigation filed by families who say that Kenvue’s Tylenol or generic versions of the pain-relief medication caused their children’s autism or attention deficit hyperactivity disorder. A lower court dismissed the cases last year, saying that the experts the plaintiffs relied on to make their case had failed to

See Full Page